Carl Zeiss Meditec AG (XSWX:AFX) 6-Month Price Index: 1.01 (As of Jul. 30, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:AFX Carl Zeiss Meditec AG XSWX:AFX
70 GF Score
Price CHF27.40
GF Value CHF67.15
! 4 Warning Signs
View Full Analysis

What is Carl Zeiss Meditec AG 6-Month Price Index?

Carl Zeiss Meditec AG XSWX:AFX +4.18% 70 6-Month Price Index is 1.01 as of Jul. 30, 2026. GuruFocus rates XSWX:AFX with a GF Score™ of 70/100 and a GF Value™ of CHF67.15. The stock has 4 warning signs investors should review.

6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. It’s calculated by current share price divided by share price 6-months ago. As of today (2026-07-30), Carl Zeiss Meditec AG's 6-Month Price Index is 1.01.

Carl Zeiss Meditec AG  (XSWX:AFX) 6-Month Price Index Explanation

Price Index (PI) also called momentum. Strategies involving Price Index are also known as momentum strategies as they allow investors to profit from a company’s stock price. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago.

The investment strategy for momentum investors is to buy winners and sell losers. That is, buy stocks that performed well and sell stocks that performed poorly in the past.

Carl Zeiss Meditec AG 6-Month Price Index Related Terms

XSWX:AFX vs ISRG, BDX, MDLN: 6-Month Price Index Comparison

For the Medical Instruments & Supplies subindustry, Carl Zeiss Meditec AG's 6-Month Price Index, along with its competitors' market caps and 6-Month Price Index data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

XSWX:AFX
70GF Score
Carl Zeiss Meditec AG XSWX:AFX
6-Month Price Index is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Carl Zeiss Meditec AG  (XSWX:AFX) 6-Month Price Index Calculation

6-Month Price Index is calculated as following:

6-Month Price Index=Current Share Price / Share Price 6-Months Ago

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 6-Month Price Index →
What does a 6-Month Price Index of 1.01 mean?
Carl Zeiss Meditec AG (XSWX:AFX) has a 6-Month Price Index of 1.01 as of Jul. 30, 2026. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. View historical data on Carl Zeiss Meditec AG and its competitors.
Is Carl Zeiss Meditec AG's 6-Month Price Index too high?
Carl Zeiss Meditec AG's current 6-Month Price Index is 1.01. Overall, Carl Zeiss Meditec AG has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Carl Zeiss Meditec AG's 6-Month Price Index compare to ISRG and BDX?
Carl Zeiss Meditec AG's 6-Month Price Index of 1.01 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 6-Month Price Index for a Medical Devices & Instruments company?
A good 6-Month Price Index depends on the Medical Devices & Instruments industry context. However, 6-Month Price Index should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 6-Month Price Index mean?
A high 6-Month Price Index can signal that a stock is expensive relative to its fundamentals. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. View historical data on Carl Zeiss Meditec AG and its competitors. Carl Zeiss Meditec AG's current 6-Month Price Index is 1.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carl Zeiss Meditec AG stock overvalued right now?
Carl Zeiss Meditec AG (XSWX:AFX) has a current 6-Month Price Index of 1.01. The stock's GF Value™ is CHF67.15, compared to a current price of CHF27.40 — trading 59.2% below its estimated fair value. The current 6-Month Price Index is 1.01. Carl Zeiss Meditec AG's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 6-Month Price Index calculated?
6-Month Price Index is calculated from a company's financial statements. For Carl Zeiss Meditec AG (XSWX:AFX), the current 6-Month Price Index is 1.01 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Carl Zeiss Meditec AG (XSWX:AFX) Overvalued in 2026?

Based on GuruFocus' analysis, Carl Zeiss Meditec AG stock appears to be undervalued. The current stock price of CHF27.40 is trading 59.2% below its estimated GF Value™ of CHF67.15.

Key valuation signals for XSWX:AFX:

  • 6-Month Price Index: 1.01
  • GF Value™: CHF67.15 vs. price of CHF27.40 (59.2% below fair value)
  • GF Score™: 70/100 with 4 warning signs

No single metric tells the full story. See the XSWX:AFX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Carl Zeiss Meditec AG Business Description

Address Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745
Carl Zeiss Meditec is one of the largest visioncare technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up about 75% of sales in 2025, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.
70GF Score

Get the complete analysis for XSWX:AFX

6-Month Price Index is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF27.40
Price
CHF67.15
GF Value